Literature DB >> 8804893

Photodynamic therapy of oral cancer. A review of basic mechanisms and clinical applications.

J M Nauta1, H L van Leengoed, W M Star, J L Roodenburg, M J Witjes, A Vermey.   

Abstract

Photodynamic therapy (PDT) is an experimental cancer treatment modality. PDT is based on the accumulation of a photosensitive dye in premalignant and malignant lesions. A certain period of time after the dye has been administered, tumor tissue may contain more of the sensitizer then the surrounding normal tissues. When tissue containing the sensitizer is exposed to light of a proper wavelength and dose, a photochemical reaction between sensitizer and light will occur. The activated photosensitizer reacts with available oxygen which subsequently damages cells and eventually may cause necrosis of the tumor. Photosensitizers can also be used for fluorescence detection. If a tumor contains more of the photosensitizer than the surrounding normal tissue, its fluorescence can potentially be utilized to detect tumors. Analogous to PDT, this can therefore be referred to as photodynamic detection (PDD). This paper reviews the basic mechanisms and clinical applications of PDT and PDD. Emphasis is placed on PDD and PDT with the photosensitizer Photofrin for detection and treatment of premalignant epithelial lesions and squamous cell carcinomas of the oral mucosa.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8804893     DOI: 10.1111/j.1600-0722.1996.tb00049.x

Source DB:  PubMed          Journal:  Eur J Oral Sci        ISSN: 0909-8836            Impact factor:   2.612


  2 in total

Review 1.  Photodynamic therapy in dentistry: a literature review.

Authors:  Hare Gursoy; Ceyda Ozcakir-Tomruk; Jale Tanalp; Selçuk Yilmaz
Journal:  Clin Oral Investig       Date:  2012-09-27       Impact factor: 3.573

Review 2.  A review of risk factors and genetic alterations in head and neck carcinogenesis and implications for current and future approaches to treatment.

Authors:  Loredana G Marcu; E Yeoh
Journal:  J Cancer Res Clin Oncol       Date:  2009-07-30       Impact factor: 4.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.